Biomm S.A.
BIOM3
Rank in Stocks
#18379
Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product... Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product portfolio features pharmaceutical and healthcare solutions, including AFREZZA, a human insulin administered as an inhalation powder, and GLARGILIN, a type of glargine insulin. The company also supplies HERZUMA, a trastuzumab, and CONFORT CARE, a moisturizing foot cream. Biomm S.A. was established in 2001 and maintains its headquarters in SΓ£o Paulo, Brazil.
Share Price
$0.97947443
Last synced: 2026-11-16
Market Cap
$134.04M
Change (1 day)
-7.89%
Change (1 year)
-25.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Biomm S.A. (BIOM3)
Category
Healthcare
EPS for Biomm S.A. (BIOM3)
EPS as of June 2026 TTM: $0.05
According to Biomm S.A.'s latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $-0.01, an increase over its 2024 EPS of $-0.10.
EPS history for Biomm S.A. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -594.00% |
| 2025 | $-0.01 | -90.78% |
| 2024 | $-0.10 | -49.50% |
| 2023 | $-0.20 | -15.23% |
| 2022 | $-0.24 | 15.46% |
| 2021 | $-0.21 | -4.31% |
| 2020 | $-0.22 | -21.88% |
| 2019 | $-0.28 | 10.48% |
| 2018 | $-0.25 | -24.75% |
| 2017 | $-0.33 | -26.99% |
| 2016 | $-0.45 | -791.34% |
| 2015 | $0.07 | -142.73% |
| 2014 | $-0.15 | -35.08% |
| 2013 | $-0.24 | -37.69% |
| 2012 | $-0.38 | 173.10% |
| 2011 | $-0.14 | -3.60% |
| 2010 | $-0.14 | -55.01% |
| 2009 | $-0.32 | -8.98% |
| 2008 | $-0.35 | 9.66% |
| 2007 | $-0.32 | -107,433.33% |
| 2006 | 0.00 | -100.17% |
| 2005 | $-0.18 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -1,901.62% |
US
|
|
| $15.66 | 31,600.40% |
US
|
|
| $-7.07 | -14,411.74% |
US
|
|
| $-5.29 | -10,808.50% |
AU
|
|
| $12.73 | 25,673.68% |
BE
|
Questions about Biomm S.A.'s earnings per share (EPS)
What is Biomm S.A.'s earnings per share (EPS)?
Biomm S.A.'s earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was Biomm S.A.'s earnings per share (EPS) in 2025?
In 2025, Biomm S.A.'s earnings per share (EPS) was $-0.01, compared with $-0.10 in 2024.
How has Biomm S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Biomm S.A.'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2022 ($-0.24).
How does Biomm S.A.'s earnings per share (EPS) compare with similar companies?
Biomm S.A.'s earnings per share (EPS) ($0.05) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.